B12-POCD: Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients

Sponsor
Xijing Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT03485404
Collaborator
First Affiliated Hospital Xi'an Jiaotong University (Other), Tang-Du Hospital (Other), Shaanxi Provincial People's Hospital (Other), The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Other), Anhui Provincial Hospital (Other), Shanghai 10th People's Hospital (Other)
40
13
3
30.6
3.1
0.1

Study Details

Study Description

Brief Summary

This study will recruit patients more than 65 years old eligible for non-cardiac surgery. Patients who participate will take either vitamin B12 and folic acid supplementation or placebo for 7 days before surgery. Neuropsychological test battery (NPB) will be tested before intervention and at discharge for determination of Post operative cognitive dysfunction (POCD). Another group of non-surgical elderly participants will also be tested for NPB to account for learning effect in POCD diagnosis. The hypothesis is that preoperative vitamin B12 supplementation will reduce the incidence of POCD in elderly patients undergoing non-cardiac surgery.

Condition or Disease Intervention/Treatment Phase
  • Drug: methylcobalamin
  • Drug: Folic Acid
  • Other: Placebo for methylcobalamin
  • Other: Placebo for folic acid
  • Procedure: non-cardiac surgery
  • Behavioral: NPB test
N/A

Detailed Description

Vitamin B12 has long been suggested to have neural nutrient effect and widely used in clinical settings for patients with peripheral nerve injury as well as complementary medicine for patients with CNS disorders, including cognitive dysfunction. Evidences showed that, although no significant improvement in cognitive function was observed in healthy elderly after vitamin B12 supplementation, some studies suggested that patients with pre-existing CNS disorder may benefit from Vitamin B12. Post operational cognitive dysfunction (POCD) is severe, and long-lasting complication that affects as high as 53% of patients in high risk surgeries. Age is an independent risk factor for POCD. Researches have shown that serum vitamin B12 level decrease with age, and methylcobalamin (active form of Vitamin B12) content in the frontal cortex of aged patients are lower than that of younger patients. However, there are no report on effect of preemptive supplementation of vitamin B12 on POCD incidence. Therefore, the current research is aimed to explore the preoperative methylcobalamin supplementation (500 mg, 3/day for 7 days before surgery) on incidence of POCD. Folic acid supplementation is a common companion for vitamin B12 treatment in clinical settings because they are in the same methionine cycle, increase of one may result in deficiency of another. So we added 5 mg, 1/day of folic acid with methylcobalamin in the treatment group.

This study will recruit patients more than 65 years old eligible for non-cardiac surgery. Patients who participate will take either vitamin B12 and folic acid supplementation or placebo for 7 days before surgery. Neuropsychological test battery (NPB) will be tested before intervention and at discharge for determination of Post operative cognitive dysfunction (POCD). Another group of non-surgical elderly participants will also be tested for NPB to account for learning effect in POCD diagnosis. The hypothesis is that preoperative vitamin B12 supplementation will reduce the incidence of POCD in elderly patients undergoing non-cardiac surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Masking Description:
Central randomization. Groups are marked as A and B with no participants, care provider, investigator and outcome assessors know which group is the drug and which is the placebo. Placebo are made as tablets that mimics the color, shape and size of the drugs.
Primary Purpose:
Prevention
Official Title:
Effect of Preoperative Vitamin B12 on Post Operative Cognitive Dysfunction in Elderly Patients Undergoing Non-cardiac Surgery: A Multi-Center, Prospective, Randomized, Double-blinded, Controlled Clinical Trial
Actual Study Start Date :
Jan 10, 2019
Actual Primary Completion Date :
Jul 29, 2021
Actual Study Completion Date :
Jul 29, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: VB12+FA

Patients will receive oral supplementation of 0.5mg methylcobalamin, 3/day and 5 mg folic acid, 1/day for 7 days before non-cardiac surgery.

Drug: methylcobalamin
methylcobalamin tablets, 0.5mg/tablet, 3 tablets/day.
Other Names:
  • vitamin B12
  • VB12
  • Drug: Folic Acid
    folic acid tablets, 5mg/tablet, 1 tablet/day
    Other Names:
  • vitamin B9
  • Procedure: non-cardiac surgery
    patients elective for non-cardiac surgery will undergo scheduled surgery after 7 days of intervention

    Behavioral: NPB test
    participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.
    Other Names:
  • neuropsychological battery tests
  • assessment of POCD
  • Placebo Comparator: Placebo

    Patients with receive oral tablets of placebo for folic acid 1/d and placebo for methylcobalamin 3/d, which look exactly like the interventional drugs as oral supplementation for 7 days before non-cardiac surgery.

    Other: Placebo for methylcobalamin
    orange tablets that looks exactly like methylcobalamin

    Other: Placebo for folic acid
    yellow tablets that looks exactly like folic acid

    Procedure: non-cardiac surgery
    patients elective for non-cardiac surgery will undergo scheduled surgery after 7 days of intervention

    Behavioral: NPB test
    participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.
    Other Names:
  • neuropsychological battery tests
  • assessment of POCD
  • Other: Non-surgical controls

    Age and sex-matched community elderly people are included for two sessions of NPB test evaluation for calculation of POCD incidence as normal control to in Z value calculation of POCd incidence to rule out learning effect.

    Behavioral: NPB test
    participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.
    Other Names:
  • neuropsychological battery tests
  • assessment of POCD
  • Outcome Measures

    Primary Outcome Measures

    1. Incidence of POCD at discharge or 7 days after operation [at discharge or at 7 days after operation if the patient is not discharged by then]

      POCD incidence is defined as two or more test of the neuropsychological battery declined as compared to preoperative baseline.

    Secondary Outcome Measures

    1. Activity daily living score [3 months after operation]

      Telephone interview of activity daily living score (14 items, 1-4 points per item, ranging 14-56 points with 56 being the worst-unable to complete any task of everyday living.)

    2. Serum level of vitamin B12, folic acid and homocysteine [Immediately before anesthesia, immediately after surgery and on the morning of postoperative day 1]

      Ten ml of venous blood will be collected from patients to test the differences of serum levels of vitamin B12, folic acid and homocysteine to show the effect of preoperative supplementation and surgery stimulation on these parameters.

    3. Serum level of cystatin C and myeloid differentiation protein 2 [Immediately before anesthesia, immediately after surgery and on the morning of postoperative day 1]

      Ten ml of venous blood will be collected from patients to test the differences of serum levels of cystatin C and myeloid differentiation protein 2.

    4. Length of hospital stay [Date from hospital admission to hospital discharge. This length is usually around 7-14 days. It may be longer if the patient have one or more complications. The length will be documented at patient discharge, up to 100 weeks.]

      to see if our intervention could reduce the total days of patient spent in hospital,

    5. Incidence of in hospital complications [From date of hospital admission to date of hospital discharge after surgery. Usually 7-14 days, assessed up to 100 weeks.]

      Overall rate of perioperative major complications including hemorrhage, deep vein thrombosis, cardiovascular complications, respiratory complications, acute kidney injury, infection or second operative needed, during patient's hospital stay.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
      1. Age equals or over 65
      1. Scheduled for spinal or joint replacement surgery under general anesthesia,estimated surgery time over 2h.
      1. Signed written informed consent obtained
      1. Non-surgical Controls are age and sex - matched community elderly residents.
    Exclusion Criteria:
      1. Disease of the central nervous system that impairs cognitive function, including all kinds of dementia, and depression
      1. MMSE score < 24
      1. Received education for less than 5 years
      1. Currently taking sedative or antidepressant drugs
      1. Has taken vitamin B12, folic acid or their derivatives (methycobalamin, cobalamin, tetrahydrofolic acid, etc.) within 6 months.
      1. Has accepted cardiac or neurological surgery within one year.
      1. Was admitted for other clinical trials within 3 month
      1. Patients that regularly taking drugs that affect vitamin B absorption, including colchicine, neomycin, salicylate.
      1. Has severe visual or auditory problems
      1. Alcohol or drug dependent (alcohol dependent: drank more than 100 mL of Chinese liqueur with alcohol concentration over 40% everyday for the past 3 months).
      1. Patients that are already admitted for this study can not be admitted the second time, no matter the cause of surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Anhui Provincial Hospital Hefei Anhui China 230001
    2 Shenzhen University General Hospital Shenzhen Guangdong China
    3 The Third Hospital of Hebei Medical University Shijiazhuang Hebei China
    4 Henan Provincial People's Hospital Zhengzhou Henan China
    5 Nanjing Drum Tower Hospital Nanjing Jiangsu China 210008
    6 First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi China 710032
    7 Shaanxi Provincial People's Hospital Xi'an Shaanxi China 710032
    8 Tangdu Hospital Xi'an Shaanxi China 710032
    9 Xijing Hospital Xi'an Shaanxi China 710032
    10 Shandong Provincial Qianfoshan Hospital Jinan Shandong China
    11 Shanghai 10th People's Hospital Shanghai China 200072
    12 Shanghai Changzheng Hospital Shanghai China
    13 Shanghai Forth People's Hospital Shanghai China

    Sponsors and Collaborators

    • Xijing Hospital
    • First Affiliated Hospital Xi'an Jiaotong University
    • Tang-Du Hospital
    • Shaanxi Provincial People's Hospital
    • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
    • Anhui Provincial Hospital
    • Shanghai 10th People's Hospital

    Investigators

    • Study Chair: Lize Xiong, M.D., Ph.D., Xijing Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Lize Xiong, Professor, Xijing Hospital
    ClinicalTrials.gov Identifier:
    NCT03485404
    Other Study ID Numbers:
    • KY20172057-1
    First Posted:
    Apr 2, 2018
    Last Update Posted:
    Aug 4, 2021
    Last Verified:
    Jul 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Lize Xiong, Professor, Xijing Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 4, 2021